By means of content research, questionnaire survey, empirical analysis and expert interview, this article analyzes the history and implementation of under-supply drugs price and supply monitoring methods and administration, summarizes the typical practice and problems in China. Based on the under-supply drugs price and supply monitoring system of National Medical Insurance Information Platform Drug and Medical Consumables Procurement Management Subsystem, the paper proposes to optimize the under-supply drugs price and supply monitoring and administration involving the online procurement policy, platform construction, monitoring methods and coordination.
Key words
under-supply drug /
price monitoring and administration /
supply monitoring and administration /
countermeasures
{{custom_sec.title}}
{{custom_sec.title}}
{{custom_sec.content}}
References
[1] 陈琳宁,丁锦希,姚雪芳,等.国外短缺药品定义及对我国的启示[J].现代商贸工业,2021,42(36): 28-30.
[2] FDA.Drug shortage staff[EB/OL].https://www.fda.gov/drugs/drug-shortage-staff.
[3] ASHP.Guidelines on managing drug product shortages[M], 2001.
[4] 宋雅梅.美国药品短缺相关法规、指南及其对我国的启示[J].中国医院药学杂志,2012,32(11): 890-893.
[5] FDA.Ninth annual report on drug shortages for calendar year 2021[M].2022.
[6] Drug shortages statistics[EB/OL].https://www.ashp.org/drug-shortages/shortage-resources/drug-shortages-statistics.
[7] 宫丽娜.美国药品短缺的法律应对研究[D].天津:南开大学,2021.
[8] 高弘杨.FDA如何应对药品短缺问题[J].中国药店,2023,(2):64-66.
[9] 黄哲,施卉,徐凤翔.中美短缺药品管理的比较与建议[J].沈阳药科大学学报,2021,38(12): 1339-1345.
[10] 王胜鹏,王翀,张弛,等.美国近期短缺药品管理策略与启示[J].中国药事, 2020, 34(10): 1191-1199.
[11] Drug shortages homepage[EB/OL].https://www.drugshortagescanada.ca.
[12] 刘倩楠,孙静,刘远立.应对药品短缺保障供应的国际实践及对我国的启示[J].中国药房, 2017, 28(18):2452-2455.
[13] Preventing drug shortages: identifying risks and strategies to address manufacturing-related drug shortages in Canada[EB/OL].https://www.drugshortagescanada.ca/blogs.
[14] Drug shortages in Canada[EB/OL].https://www.canada.ca/en/health-canada/services/drugs-health-products/drug-products/drug-shortages.html.
[15] 刘青泽,韩月,朱虹,等.国内外短缺药品监测预警体系对比分析[J].中国药业, 2019, 28(18): 1-4.
[16] 何梦婷,冯国忠,周振,等.国外药品短缺处理机制的比较及对我国的启示[J].中国药事, 2017, 31(9):980-983.
[17] 邵蓉,孙海顺,张梦.英国短缺药品联络人报告制度对我国的启示[J].卫生经济研究, 2016, (12): 22-25.
[18] 房冰.药品短缺的防范及管控策略研究[D].郑州:郑州大学,2021.
[19] A reinforced role for the European Medicines Agency in crisis preparedness and management for medicinal products and medical devices[EB/OL].https://eur-lex.europa.eu/legal-content/EN/TXT/?uri=CELEX%3A32022R0123.
[20] 杨露.云南省短缺药品监测指标设计及处置体系构建研究[D].昆明:昆明医科大学,2022.
[21] 国家卫健委:推进短缺药品信息化管理建设,全力以赴做好重点药品供应保障[EB/OL].(2021-05-26)[2023-09-20].https://baijiahao.baidu.com/s?id=1700806153256522573&wfr=spider&for=pc.
